Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Interleukin 6 (IL-6) signaling pathway is a crucial regulator of immune responses, inflammation, and hematopoiesis. It involves the binding of IL-6 to its receptor complex (IL-6Rα and gp130), leading to the activation of intracellular signaling cascades such as JAK/STAT, MAPK, and PI3K/AKT. The pathway operates through classical and trans-signaling mechanisms, with distinct effects on inflammation and tissue homeostasis. Dysregulation of IL-6 signaling is implicated in various diseases, including autoimmune disorders, chronic inflammation, and cancer.
Varies depending on the specific target within the pathway (e.g., receptor blockade for IL-6 and IL-6R targeting antibodies). JAK inhibitors also disrupt signaling downstream.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 6 Signaling Pathway (IL-6 Signaling).